---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-184004"
form_type: "8-K"
ticker: null
cik: "0001718108"
company_name: "Surface Oncology, Inc."
filed_at: "2023-07-10T23:59:59+00:00"
generated_at: "2026-06-13T10:37:36.978834+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Surface Oncology transfers to Nasdaq Capital Market; gets extended compliance period to Jan 2, 2024

## Summary
- Stock transferred from Nasdaq Global Market to Capital Market effective July 10, 2023; ticker remains SURF.
- Extended compliance period until January 2, 2024 to regain $1.00 minimum bid price.
- Company will consider reverse stock split to regain compliance; no assurance of success.
- Previously disclosed bid price deficiency on Jan 6, 2023; initial 180-day period expired July 5, 2023.

## SEC filing metadata
- accession: 0001193125-23-184004
- form_type: 8-K
- cik: 0001718108
- company_name: Surface Oncology, Inc.
- filed_at: 2023-07-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1718108/000119312523184004/0001193125-23-184004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1718108/000119312523184004/d533683d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-184004
- JSON: https://secwatch.observer/filing/0001193125-23-184004.json
- Plain text: https://secwatch.observer/filing/0001193125-23-184004.txt

## Key facts
- Listing & Compliance Notices
  Surface Oncology, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: July 6, 2023, Nasdaq notified the Company that the Transfer was approved, and that, in connection with the Transfer, the Company was eligible for an additional 180 calendar day period, or until January 2, 2024 (the “Extended Compliance Date”), to regain compliance with Rule 5550(a)(2). Effective at the opening of business on July 10, 2023, the Common Stock will be transferred to the Nasdaq Capital Market. The Common Stock will continue to trade under the symbol “SURF.” The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, but with less stringent listi
  evidence_url: https://www.sec.gov/Archives/edgar/data/1718108/000119312523184004/0001193125-23-184004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.